Discovery of hALPL Agonists for Osteogenesis from A Selenium-containing DNA-encoded Natural Product Library

Authors:

Abstract
Tissue-nonspecific alkaline phosphatase (hALPL) deficiency or dysfunction is a key driver of bone developmental abnormalities. However, no small-molecule agonists are available for the therapeutic target hALPL—particularly its pathogenic mutants. We bridge this gap by developing an antibody maturation-inspired chemical maturation strategy that integrates DNA-encoded library (DEL) selection with parallel synthesis for rapid functional chemical discovery. Using a selenium-containing DNA-encoded natural product library (Se-nDEL), comprising 25900 selenium-containing derivatives and affinity-based selection, we identified hALPL-binding candidates. The candidates were further functionally matured via selenium-nitrogen exchange (SeNEx) chemistry-enabled in situ nanomole-scale parallel synthesis. These efforts culminated in the identification of E7, the first small-molecule hALPL agonist, which directly binds to and activates hALPL, thereby promoting osteogenesis both in vitro and in vivo. Notably, E7 demonstrated the ability to restore the enzymatic activities of seven pathogenic mutations, further highlighting its therapeutic potential. Our work establishes a scalable platform for agonist development, combining DEL-driven hit discovery with parallel synthesis for functional optimization, with broad applicability to challenging targets in bone biology and beyond.

This publication has 65 references indexed in Scilit: